| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/05/2010 | EP1790655B1 Biologically active peptides |
| 05/05/2010 | EP1326847B1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 05/05/2010 | CN1976947B Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 05/05/2010 | CN1964729B Composition for prevention and treatment of urinary incontinence |
| 05/05/2010 | CN1853708B Use of Galangal fruit and its extract in pharmacy |
| 05/05/2010 | CN1823979B Medicinal tablet for treating prostate disease and its preparation method |
| 05/05/2010 | CN1809353B Medicine for prevention of and treatment for arteriosclerosis and hypertension. |
| 05/05/2010 | CN1642574B Remedies for glomerular diseases |
| 05/05/2010 | CN1630526B Systems and methods for treating patients with processed lipoaspirate cells |
| 05/05/2010 | CN101700387A Compound snow ginseng capsule |
| 05/05/2010 | CN101700370A Method for preparing pharmaceutical composition for treating diseases of urinary system and method for detecting components thereof |
| 05/05/2010 | CN101700368A Method for detecting components of pharmaceutical composition for treating diseases of urinary system |
| 05/05/2010 | CN101700367A Pharmaceutical composition for treating diseases of urinary system and method for detecting components thereof |
| 05/05/2010 | CN101700346A Formulation of oral traditional Chinese medicine for treating ureteral calculi |
| 05/05/2010 | CN101700343A Traditional Chinese medicine for treating prostatitis |
| 05/05/2010 | CN101700340A Oral traditional Chinese medicine composition for treating chronic nephritis |
| 05/05/2010 | CN101700334A Chinese herbal preparation for treating prostatic hypertrophy |
| 05/05/2010 | CN101700327A Drug for treating prostatitis and preparation method |
| 05/05/2010 | CN101700326A Preparation method of traditional Chinese medicine preparation for clearing heat and promoting urination for treating stranguria |
| 05/05/2010 | CN101700265A Application of pseudo-ginseng and extract thereof in preparing medicament for curing and/or preventing diabetic microangiopathies |
| 05/05/2010 | CN101700262A Quality control method of andrographis paniculata dropping pills |
| 05/05/2010 | CN101700260A Purslane seed polysaccharide granule preparation and preparation method thereof |
| 05/04/2010 | US7709640 Inhibitors of phosphorylation of platelet derived growth factor receptor |
| 05/04/2010 | US7709519 2-(1,3-Dihydro-2H-benzimidazol-2-ylidene)-1-[3-(1,2-dihydroxyethyl)phenyl]-3-(3,4,5-trifluorophenyl)propane-1,3-dione; GnRH receptor antagonism; prostate cancer, breast cancer, endometriosis, uterine leiomyoma, benign prostatic hypertrophy; good availability by oral administration |
| 05/04/2010 | US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease |
| 05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
| 05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 05/04/2010 | US7709500 Chemical compounds |
| 05/04/2010 | US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives |
| 05/04/2010 | US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/04/2010 | US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 05/04/2010 | US7709457 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol |
| 05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
| 05/04/2010 | US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents |
| 05/04/2010 | CA2431519C Topical composition and method for treating urinary stress incontinence |
| 05/04/2010 | CA2427608C Condensed pyradizindione derivatives as pde inhibitors |
| 05/04/2010 | CA2337213C Therapeutic agent for renal failure containing 4,8-inter-m-phenylene prostaglandin i2 derivative |
| 04/29/2010 | WO2010047765A2 Nanostructures for drug delivery |
| 04/29/2010 | WO2010047369A1 Agent for treatment of diabetic nephropathy |
| 04/29/2010 | WO2010045871A1 Composition and method for treating proteinuria |
| 04/29/2010 | WO2010045755A1 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof |
| 04/29/2010 | US20100105953 Human Adam-10 Inhibitors |
| 04/29/2010 | US20100105922 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
| 04/29/2010 | US20100105896 Pharmaceutical compounds |
| 04/29/2010 | US20100105757 Treatment and inhibition of disease conditions using flexible heteroarotinoids |
| 04/29/2010 | US20100105701 Gyrase inhibitors and uses thereof |
| 04/29/2010 | US20100105651 Antagonists of sns sodium channels |
| 04/29/2010 | US20100105621 Therapies for acute renal failure |
| 04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
| 04/29/2010 | US20100104657 Pharmaceutical composition comprising a reduced concentration of cholesterol |
| 04/29/2010 | US20100104631 Method of treatment for bladder dysfunction |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104558 Use of an EGFR Antagonist for the Treatment of Glomerolonephritis |
| 04/29/2010 | US20100104544 Selective cell therapy for the treatment of renal failure |
| 04/29/2010 | DE102008053044A1 Composition, useful for preventing and/or treating renal dysfunction, preferably renal failure, comprises combination of calcium salt as first active component, and magnesium salt, as second active component |
| 04/28/2010 | EP2179999A1 Fused tricyclic compound having aldose reductase inhibitory activity |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP2178858A1 Novel heterocyclic compounds as mglu5 antagonists |
| 04/28/2010 | EP2178520A1 Drug formulations having inert sealed cores |
| 04/28/2010 | EP1590321B1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 04/28/2010 | EP1572173B1 Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 04/28/2010 | EP1472225B1 2-piperazine-pyridines useful for treating pain |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 04/28/2010 | EP0831858B1 Intrauterine chemical necrosing method and composition |
| 04/28/2010 | CN201441642U Kidney-shaped special-shaped tablet |
| 04/28/2010 | CN1860228B Staple type oligonucleotide and drug comprising the same |
| 04/28/2010 | CN1824205B Medicine for treating chronic prostatitis and its preparation method |
| 04/28/2010 | CN1717252B Preparation containing basic drug |
| 04/28/2010 | CN1691965B Pharmaceutical composition for controlled release and manufacturing method thereof |
| 04/28/2010 | CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/28/2010 | CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine, |
| 04/28/2010 | CN1496271B Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 04/28/2010 | CN101698816A Coix seed wine and coix seed ginseng root wine |
| 04/28/2010 | CN101698087A Quality test method of Yidan tablets |
| 04/28/2010 | CN101698076A Traditional Chinese preparation for tonifying kidney and Yang |
| 04/28/2010 | CN101698066A Chinese medicine preparation capable of diminishing inflammation, relieving pains, resisting bacteria, expelling stone and benefiting gallbladder, and preparation method and applications thereof |
| 04/28/2010 | CN101698010A Traditional Chinese medicine composite for treating prostatitis and prostate hyperplasia |
| 04/28/2010 | CN101014560B Wikstroemia indeca extract, their production and use in the production of anti-inflammatory pharmaceutical |
| 04/27/2010 | US7705195 Screening method |
| 04/27/2010 | US7705182 Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 04/27/2010 | US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils |
| 04/27/2010 | US7705039 Method for treating sleep apnea |
| 04/27/2010 | US7704999 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/27/2010 | US7704976 Promoting repair of skin and mucous membrane tissues, the product of the present invention exhibits unique effects for controlling inflammation, damage, infection, and exudation; side effect reduction; topical administration |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704947 Methods and compositions for the treatment of gastrointestinal disorders |
| 04/27/2010 | US7704498 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/27/2010 | CA2321951C Dietary control of arachidonic acid metabolism |
| 04/22/2010 | WO2010045558A1 Method of determining a phosphorus binder dosage for a dialysis patient |
| 04/22/2010 | WO2010045166A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/22/2010 | WO2010044411A1 Phenylisonicotinic acid derivative and use thereof for medical purposes |
| 04/22/2010 | WO2010044410A1 Biaryl isonicotinic acid derivative and medical application of same |
| 04/22/2010 | WO2010044405A1 Fused-ring derivative and medical application of same |
| 04/22/2010 | WO2010044404A1 Fused heterocyclic derivative and use thereof for medical purposes |
| 04/22/2010 | WO2010044403A1 5-membered heteroaryl derivative and use thereof for medical purposes |
| 04/22/2010 | WO2010043408A2 Microencapsulated fesoterodine |
| 04/22/2010 | WO2010042997A1 Compositions and methods for treatment of kidney disorders |